Epidemiology of companion animal AMR in the United States of America: filling a gap in the one health approach

Front Public Health. 2023 Jun 16:11:1161950. doi: 10.3389/fpubh.2023.1161950. eCollection 2023.

Abstract

Introduction: Antimicrobial resistance (AMR) is a global health concern that affects all aspects of the One Health Triad, including human, animal, and environmental health. Companion animals, such as cats and dogs, may contribute to the spread of AMR through their close contact with humans and the frequent prescription of antimicrobials. However, research on AMR in companion animals is limited, and there are few surveillance measures in place to monitor the spread of resistant pathogens in the United States.

Methods: This study aims to explore the practicality of using data from commercial laboratory antimicrobial susceptibility testing (AST) services for epidemiological analyses of AMR in companion animals in the United States.

Results: The study analyzed 25,147,300 individual AST results from cats and dogs submitted to a large commercial diagnostic laboratory in the United States between 2019 and 2021, and found that resistance to certain antimicrobials was common in both E. coli and S. pseudintermedius strains.

Conclusion: There has been a paucity of information regarding AMR in companion animals in comparison to human, environmental and other animal species. Commercial AST datasets may prove beneficial in providing more representation to companion animals within the One Health framework for AMR.

Keywords: E. coli; S. pseudintermedius; antimicrobial resistance; companion animal; epidemiology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Cats
  • Dogs
  • Escherichia coli*
  • Humans
  • Laboratories
  • One Health*
  • Pets
  • United States / epidemiology

Substances

  • Anti-Bacterial Agents